TAIWAN · TWSE / TPEx
LI KANG
立康 · 6242 · TPEx (OTC) · Biotech and medical
Share price, 2026-10-16NT$34.001 month +0.9% · 1 year -10.9%
Directors and supervisors hold6,448,35320.3% of shares issued
Of which pledged0.0%0
Major shareholders (10%+) hold16,155,79950.8% of shares issued
Revenue, 2026-09+7.6%year on year
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 宏育投資股份有限公司 | Chairman · Director | 344,991 | 344,991 | 1.08% | — | — |
| 鄭育修 | Chairman (corporate representative) · President | — | 174,756 | 0.55% | — | 250,000 |
| 立康生物科技股份有限公司 | Director · Major shareholder (10%+) | 6,103,362 | 6,103,362 | 19.19% | — | — |
| 黃雅翌 | Director (corporate representative) | — | 250,000 | 0.79% | — | 174,756 |
| 李慧千 | Director (corporate representative) | — | 0 | — | — | — |
| 林宏源 | Director (corporate representative) | — | 0 | — | — | 166,326 |
| 黃釋瑩 | Independent director | — | 0 | — | — | — |
| 鮑力恒 | Independent director | — | 0 | — | — | — |
| 陳志昌 | Independent director | — | 0 | — | — | — |
| 陳志麟 | Independent director | — | 0 | — | — | — |
| 莊祐霖 | Assistant vice president | — | 164,031 | 0.52% | — | 4,899 |
| 生春堂製藥工業股份有限公司 | Major shareholder (10%+) | — | 10,052,437 | 31.60% | — | — |
| 林麗郁 | Chief financial officer · Chief accountant | — | 10,230 | 0.03% | — | — |
| 高碧婕 | Other | — | 6,000 | 0.02% | — | — |